Type I Interferon Therapy Limits CNS Autoimmunity by Inhibiting CXCR3-Mediated Trafficking of Pathogenic Effector T Cells

Weiwei Wang(Suzhou Research Institute), Jun Chen(Sun Yat-sen University), Igal Gery(National Eye Institute), Sihan Wu(Shanghai Changzheng Hospital), Wai Po Chong(Hong Kong Baptist University), Chunmei Li(Sun Yat-sen University), Yizhi Liu(Guizhou University), Wanjun Chen(National Institutes of Health), Zilin Chen(China Academy of Chinese Medical Sciences), Rachel R Caspi(National Institutes of Health), Hongyan Zhou(Sun Yat-sen University), Ying Wan(Gilead Sciences (United States))
Cell Reports
July 1, 2019
Cited by 31


Related Papers